FDA Clearance Tracker · P240027
SpineSeal Spine Sealant
Last checked: Nov 20, 2026Latest source record: Feb 14, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Feb 14, 2025
Approved
Time to decision
179 days
Received Aug 19, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P240027
- Device name
- SpineSeal Spine Sealant
- Applicant
- Pramand, LLC
- Applicant location
- Bedford, MA
- Received
- Aug 19, 2024
- Decided
- Feb 14, 2025
- Decision
- Approved
- Supplements
- 5 in FDA's data for this PMA. See them on the FDA record
Device type
- Device type
- Sealant, dural (NQR)
- Device class
- Class III
- Specialty
- Neurology & Neurosurgery
FDA's approval statement
As written in FDA's record.
The SpineSeal Spine Sealant is indicated for use as an adjunct to sutured dural repair during spinal surgery to provide watertight closure.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code NQR. The earliest in FDA's data is P040034, decided Apr 7, 2005.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Pramand, LLC
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P220014 · Decided Jul 6, 2023 · 307 days after receipt
Device type: Sealant, dural (NQR) · Neurology & Neurosurgery
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.